Gremošanas slimību biedrība

12/09/2025

👉 Gastroenteroloģija – plaša specialitāte, kas sākas jau ar mutes dobumu!

📍 Ar prieku izziņojam vienu no XII Latvijas Gastroenteroloģijas kongresa izcilākajām lekcijām:

“From Mouth to Gut: The Impact of Periodontal Treatment on Systemic Inflammation and GI Health”
(Periodontālās ārstēšanas ietekme uz sistēmisko iekaisumu un kuņģa-zarnu trakta veselību)

📅 2025. gada 29. novembris

📍 ATTA Centre, Rīga

🌍 Starptautisks pasākums ar vairākiem dalībniekiem

🔗 www.gastro2025.com

🎓 Lekciju prezentēs Dr. med. Zane Lauriņa, daloties ar jaunākajām atziņām par saikni starp mutes veselību un kuņģa-zarnu trakta slimībām.

28/08/2025

🩺 XII Latvijas Gastroenteroloģijas Kongress ar Starptautisku dalību

📅 29. novembris • Rīga

🎓 Vismaz +8 TIP par galveno kongresu un papildu TIP par katru satelītu

⏳ Agrā reģistrācija līdz 15. septembrim — līdz €65

👉 Reģistrācija:

https://www.gastro2025.com/

No XI Latvijas Gastroenteroloģijas Kongresa ar Starptautisku dalību mūs šķir tikai 2 gadi, bet jaunumu ir daudz: gan ārzemēs, gan mūsu valstī

24/08/2025

🌍 Healthcare is not only about treatment — it’s about access, affordability, and long-term sustainability.

📈 That’s why I challenged myself to go beyond the purely clinical perspective and completed the Harvard Business School Online course in Health Care Economics.

💡 Key takeaway? Even the best innovations mean little if systems cannot support their implementation.

🤝 I truly believe our mission is to bridge the gap between medical excellence and economic reality.

21/08/2025

👉 A glimpse of our exceptional speakers in gastroenterology and hepatology - the full line-up awaits you on September 5–6!

29/05/2025

🧠🦠 The gut microbiota - our "virtual organ" -has emerged as a central player in human health.

🎯 Over the past decades, research has revealed the gut microbiota’s vital role in both physiological and pathological processes. It acts like a virtual organ, influencing immunity, metabolism, and even brain function. We've come to understand multiple communication pathways - the gut-brain, gut-liver, gut-lung axes, and beyond. 🦠

👉 Among these, the gut–liver axis is especially significant. The gut and liver are deeply interconnected, constantly communicating through bidirectional signaling pathways involving metabolites, immune cells, and the portal circulation.

That’s why we’re thrilled 🎆 to share our latest review article, just published in Microorganisms:

📘 “Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies”

🧬 In this paper, we explore how gut dysbiosis contributes to the progression of liver disease and discuss future microbiome-based therapeutic strategies.

🆓 The article is open-access and freely available here: https://www.mdpi.com/2076-2607/13/5/1053

Chronic viral hepatitis B and C remain major global health challenges, contributing significantly to liver-related morbidity and mortality. Despite antiviral therapies and vaccines for HBV, progression to cirrhosis and hepatocellular carcinoma remains common. For HCV, the lack of a vaccine and high....

23/04/2025

We’re thrilled to share some exciting news - we’ve officially joined AmCham Latvia! 🇱🇻🇺🇸

As an organization deeply involved in healthcare, education, and professional networking, this step opens up amazing opportunities to connect with a diverse community of innovators, leaders, and changemakers.

Through , we’re looking forward to:

🩺 Supporting conversations that shape the future of healthcare;
📚 Engaging in initiatives that promote educational excellence;
🤝 Building meaningful connections across industries.

Joining means becoming part of a powerful platform that drives real impact - locally and globally. We’re proud to be among members who believe in collaboration, progress, and shared values.

We’re excited to connect, collaborate, and contribute to positive changes in the local and international business landscape. 💼✨

Looking forward to the journey ahead with AmCham! 🇱🇻🇺🇸

01/04/2025

🌍 Grateful to Participate in an Inspiring Workshop on SBS and Intestinal Failure Management 💡
📍 Ljubljana, Slovenia | Organized by the Institute of Oncology Ljubljana

🎓I recently had the opportunity to attend a focused workshop dedicated to Short Bowel Syndrome (SBS) and Intestinal Failure (IF) - challenging conditions that require specialized, multidisciplinary care and long-term support strategies.

🔬 SBS and IF are complex gastrointestinal disorders where patients often struggle with nutrient absorption, chronic malnutrition, and dependency on parenteral nutrition. The workshop offered valuable insights into current best practices in diagnosis, surgical and nutritional management, and improving patient quality of life.

I'm truly thankful 🙌 to the Institute of Oncology Ljubljana for organizing this enriching event and to all the experts, especially prof. Nada Rotovnik Kozjek and colleagues who shared their experience and knowledge.

It was a great opportunity to connect with dedicated professionals and discuss real-world approaches to managing these demanding conditions.

🙏 Special thanks to Takeda for providing support and helping make this workshop possible.

Looking forward to future collaborations in this field! 🤝

17/03/2025

🎆Finally, our European Consensus is published! 👏

👉 Malabsorption is an incredibly complex and highly challenging condition for medical specialists worldwide. 🌐 A vast array of diseases can contribute to its development, making diagnosis a demanding process and treatment a formidable task. Despite its significance, there has long been a lack of comprehensive guidelines on this intricate topic - until now! 📕

👉We are thrilled to announce that our 🇪🇺 Pan-European Consensus 🤝 on Malabsorption has just been published in the Journal, providing much-needed clarity on screening, nutritional support, and even the role of primary care in managing this condition.

👉It has been an absolute privilege to collaborate with so many renowned and esteemed specialists in the field. A special thanks 🙏 to , whose vision, leadership, and dedication brought our team together and guided us to this major achievement. And of course, immense gratitude to for their invaluable support in making this possible!

This article is open access and can be accessed here: https://doi.org/10.1002/ueg2.70011

03/03/2025

🎯It was a great honor and an extremely valuable experience to participate in the annual ERN RARE-LIVER Members' Meeting at the end of January. This year, the event was hosted by Hospital Clinic de Barcelona. 🇪🇸

🤝 The meeting underscored our ongoing international collaboration in the field of rare liver diseases across the EU 🇪🇺 , providing a platform to share expertise, strengthen cross-ERN cooperation, and enhance networking with other clinical teams.

A special thanks 🙏 to the ERN RARE-LIVER Office Team and the Barcelona Team for organizing such a well-executed event, making it a resounding success.

26/12/2024

👉 Antimicrobial resistance (AMR) poses a significant challenge to global public healthcare. 🩺 It also directly and indirectly affects other sectors, including food production, veterinary and the environment. Various projections suggest that AMR-related mortality in the near future could surpass that of diabetes mellitus and cancer. ⌛️

🌐 For nearly a decade, the global initiative World Antimicrobial Awareness Week has been raising awareness 🫵 and promoting action to combat resistance, celebrated worldwide at the end of November under the slogan: Spreading Awareness, Stopping Resistance!

👏 We are delighted that this year, on November 29th, in collaboration with the Latvian Rural Family Physicians Association, we organized a conference at the Radisson Blu Daugava dedicated to this critical and complex issue. The event brought together over 130 healthcare professionals to discuss the multifaceted aspects of AMR. 🎓

🤝 We extend our heartfelt gratitude to Dr. Līga Kozlovska and Dr. Gaida Bērziņa, as well as to all participants, speakers, and supporters, who contributed to the conference's success.

🛑 Let’s act responsibly with antibiotics💊 while we still can! Misusing antibiotics globally does not make us global winners, but global losers! 🫷

09/12/2024

📍 It was an exciting and valuable experience to recently participate in the COST (The European Cooperation in Science and Technology) Action Management Committee meeting in Brussels 🇪🇺, representing my country 🇱🇻 in this significant project. 🙏 This Action brought together participants from over 25 countries, fostering collaboration 🤝 and the exchange of expertise on a global scale. This our initiative aims to establish the European Vascular Liver Diseases Network (EURO-VALDI-NET), fostering collaboration among diverse groups such as clinicians, scientists, stakeholders etc. 🏦

As an added bonus, the meeting also offered the opportunity to enjoy the fabulous sights 🏙 of downtown Brussels during breaks from the COST Headquarters. 👌

24/11/2024